| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Revenue | $6K | -48.9% |
| R&D Expense | $165K | +37.6% |
| SG&A Expense | $879K | +15.2% |
| Operating Income | -$1.0M | -18.3% |
| Interest Expense | $10K | -58.7% |
| Pre-tax Income | -$1.0M | -16.9% |
| Net Income | -$930K | -17.6% |
| EPS (Basic) | -$0.01 | +70.0% |
| EPS (Diluted) | -$0.01 | +70.0% |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $583 | +0.0% |
| Current Assets | $440K | -40.1% |
| Total Assets | $440K | -40.1% |
| Current Liabilities | $885K | +43.0% |
| Long-term Debt | $18K | -84.8% |
| Total Liabilities | $903K | +6.4% |
| Stockholders' Equity | $178K | +256.2% |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$632K | -100.2% |
| Financing Cash Flow | $368K | -59.6% |